Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$427.25
+0.3%
$427.27
$396.68
$603.88
$151.31B1.462.15 million shs6,091 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%+5.27%+0.94%-5.87%-21.65%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$427.25
+0.3%
$427.27
$396.68
$603.88
$151.31B1.462.15 million shs6,091 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%+5.27%+0.94%-5.87%-21.65%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$573.4234.21% Upside

Current Analyst Ratings Breakdown

Latest ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price Target$520.00 ➝ $515.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOverweight$580.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetSell$440.00 ➝ $366.00
5/27/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price Target$558.00
5/19/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingHold (C)
5/18/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetBuy$650.00 ➝ $520.00
4/23/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price TargetOverweight$712.00 ➝ $651.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetBuy$653.00 ➝ $604.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Boost Price TargetOutperform$575.00 ➝ $610.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Boost Price TargetBuy$609.00 ➝ $621.00
(Data available from 7/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B15.03$9.30 per share45.92$50.52 per share8.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2551.7943.513.4728.15%15.98%14.07%7/16/2026 (Estimated)

Latest ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/16/2026Q2 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.48N/AN/AN/A$2.82 billionN/A
4/21/2026Q1 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.61
3.59

Institutional Ownership

CompanyInstitutional Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%

Insider Ownership

CompanyInsider Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021354.16 million352.04 millionOptionable

Recent News About These Companies

Strs Ohio Trims Stake in Intuitive Surgical, Inc. $ISRG

New MarketBeat Followers Over Time

Media Sentiment Over Time

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$427.25 +1.24 (+0.29%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.